Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
Clinical trial NCT00589875 · COMPLETED
Trial details
- NCT number
- NCT00589875
- Sponsor
- Candel Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2015-12-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.